Agilent Fiscal Q1 Revenues up 2 Percent; Lowers 2015 Guidance | GenomeWeb

NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market on Tuesday that revenues for its fiscal first quarter rose 2 percent year over year, as the company matched the average analysts' estimates on the top and bottom lines. 

For the three months ended Jan. 31, Agilent record $1.03 billion in revenues, equaling the consensus Wall Street estimate. Agilent CFO Didier Hirsch said on a conference call following the release of the firm's financial results that currency effects negatively impacted Q1 2015 revenues by $12 million and EPS by $.01.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.